Dr. Friedman on the Future of Selinexor in Multiple Myeloma

Dr. Friedman on the Future of Selinexor in Multiple Myeloma

Dr. Friedman on the Future of Selinexor in Multiple Myeloma Robb S. Friedman, MD, a hematologist and oncologist at Massachusetts General Hospital, discusses the future of selinexor (Xpovio) in multiple myeloma. Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive

Read More